Specific determination of plasmin inhibitor activity in plasma: Documentation of specificity of manual and automated procedures

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 8, 1999, Pages 487-494

  Clason, S Billing ^a   Meijer, P ^b   Kluft, C ^b   Ersdal, E ^a  

^a Chromogenix AB   (Sweden)

^b TNO   (Netherlands)

Author keywords

A2 antiplasmin; Activity assay; Automated; Plasmin inhibitor

Indexed keywords

ANTIPLASMIN; PLASMIN;

ARTICLE; AUTOMATION; BLOOD ANALYSIS; BLOOD CLOTTING; HEMOSTASIS; LABORATORY; PRIORITY JOURNAL; TECHNIQUE;

EID: 0033377707     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199912000-00006     Document Type: Article

References (20)

1. Collen D, Wiman B. Fast-acting plasmin inhibitor in human plasma. Blood 1978; 51: 563-569.
2. Booth NA. The natural inhibitors of fibrinolysis. In: Bloom AL, Forbes CH, Thomas DP, Tuddenham EGD (editors): Haemostasis and thrombosis. Edinburgh: Churchill Livingstone; Vol. 1. 1994. pp. 699-717.
3. Aoki N. Hemostasis associated with abnormalities of fibrinolysis. Blood Reviews 1989; 3: 11-17.
4. 2-antiplasmin deficiency, an overlooked cause of haemorrhage. The American Journal of Pediatric Hematology/Oncology 1993; 15(3): 328-330.
5. 2-plasmin inhibitor levels in liver diseases. Clin Chim Acta 1978; 84: 99-105.
6. 2-Plasmin inhibitor is among acute phase reactants. Thromb Res 1980; 17: 527-532.
7. Teger-Nilsson A-C, Friberger P, Gyzander E. Determination of a rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest 1977; 37: 403-409.
8. 2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate. Thromb Res 1978; 12: 1147-1156.
9. Gallimore MJ, Amundsen E, Aasen AO, Larsbraaten M, Lyngaas K, Svendsen L. Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate. Thromb Res 1978; 14: 51-60.
10. Friberger P. Chromogenic peptid substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin system. Scand J Clin Lab Invest 1982; 42,(suppl 262): 403-409.
11. 2-antiplasmin on the automated coagulation analyzer MLA Electra 1000C. Fibrinolysis 1994; 8(suppl 2): 160-162.
12. Woodham B. Letter to the Editor. Fibrinolysis 1995; 9: 129-131.
13. 2-antiplasmin activity measurement in plasma [abstract 938]. Thromb Haemostasis 1995; 73: 1145.
14. Meijer P, Kluft C. Criteria for an automated specific plasmin inhibition test (SPIT) in human plasma. Fibrinolysis 1996; 10(suppl 2):121-123.
15. Billing-Clason S, Meijer P, Kluft C, Ersdal E. A novel method, Coamatic® Plasmin Inhibitor, for the specific determination of plasmin inhibitor activity in plasma. Fibrinolysis 1996; 10(suppl 2): 165-167.
16. 2-Antiplasmin activity. In: Jespersen J, Bertina RM, Haverkate F (editors): ECAT assay procedures, a manual of laboratory techniques. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1992. pp. 165-171.
17. 2-antiplasmin. Blood 1982; 95: 1169-1180.
18. 2-antiplasmin molecule associated with an autosomal recessive haemorrhagic disorder. J Clin Invest 1987; 80: 1391-1400.
19. 2-antiplasmin and plasmin stopped-flow fluorescence kinetics. FEBS Lett 1996; 387: 58-62.
20. 2-macroglobulin-proteinase interactions. Studies with trypsin and plasmin. Biochemistry 1984; 23: 6619-6626.